Apotheek Ravestijn
Board
1 director, 1 in day-to-day management, last change in 2025Director and managing director, permanent representative
in office according to the deed of 17-05-2013
6-year term from 2025
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayManaging director
Director
LeadershipEarlierRest of the termmandate already running before its first mention
Mandates as a list
-
- Director, from before 02-01-2013 to 03-01-2025
- Managing director, since before 02-01-2013
-
- Director, from before 02-01-2013 to 03-01-2025
Control
Parent
Equity €674,044
Profit €23,911 in 2025 (profit €56,638 in 2024)
Source: accounts 31-03-2025
100%
This company
Apotheek Ravestijn
Equity €188,072
Loss €4,758 in 2024
Capital
- Capital
- €62,000
- Shares
- 1,250
- Contribution per share
- €49.60
- Equity per share
- €150 in 2024
- Source
- deed of 19-02-2024
Owners through the years
as the annual accounts name themOwners as a list
-
- 2008 to 2025: 100%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 19-02-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle verrichtingen in wet vermeld, algemene vergadering anders bij gewone meerderheid”